SCHEMBL2253922

SCHEMBL2253922

O=C(O)c1ccc(-c2ccc(F)cc2)cc1/C=C/c1ccc2c(C(=O)O)cccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.70
▸ BAD Q92934 1/20 0.70
▸ PTPN1 P18031 1/20 0.44
▸ TRPM2 O94759 1/20 0.41
▸ DHODH Q02127 3/20 0.39
▸ NR4A1 P22736 1/20 0.39
▸ NR4A2 P43354 1/20 0.39
▸ NR4A3 Q92570 1/20 0.39
▸ GRIK1 P39086 1/20 0.39
▸ GRIA1 P42261 1/20 0.39
▸ GRIA2 P42262 1/20 0.39
▸ GRIA3 P42263 1/20 0.39
▸ GRIA4 P48058 1/20 0.39
▸ GRIK2 Q13002 1/20 0.39
▸ GRIK3 Q13003 1/20 0.39
▸ RELA Q04206 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ CYP1B1 Q16678 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253926 1.00 BCL2L1 (0.70) BCL2L1BADPTPN1TRPM2DHODH
SCHEMBL2251565 0.91 BCL2L1 (0.67) BCL2L1BADPTPN1DHODHRELA
SCHEMBL2251560 0.91 BCL2L1 (0.67) BCL2L1BADPTPN1DHODHRELA
SCHEMBL2255104 0.84 BCL2L1 (0.67) BCL2L1BADPTPN1DHODHRELA
SCHEMBL2251156 0.84 BCL2L1 (0.67) BCL2L1BADTRPM2DHODHGRIK1
SCHEMBL2255098 0.84 BCL2L1 (0.67) BCL2L1BADPTPN1DHODHRELA
SCHEMBL2251163 0.84 BCL2L1 (0.67) BCL2L1BADTRPM2DHODHGRIK1
SCHEMBL2254358 0.84 BCL2L1 (0.77) BCL2L1BADPTPN1TRPM2TRPA1
SCHEMBL2254360 0.84 BCL2L1 (0.77) BCL2L1BADPTPN1TRPM2TRPA1
SCHEMBL2253708 0.83 BCL2L1 (1.00) BCL2L1BADPTPN1TRPM2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885PTPN1 3895/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885PTPN1 3895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback